ASCO® 2026 Highlights: Presenter Vignette – Linda Mileshkin

Dr. Linda Mileshkin

Linda Mileshkin

MD, MBBS, FRACP

Peter MacCallum Cancer Centre

5515

Updated safety and efficacy of puxitatug samrotecan (Puxi-Sam, AZD8205) in patients (pts) with endometrial cancer (EC) or ovarian cancer (OC): Phase 1/2a BLUESTAR study.